Stonebridge Financial Planning Group’s VanEck Biotech ETF BBH Stock Holding History

Stonebridge Financial Planning Group’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,345	Closed	-$209K	–	149
2023 Q3	$209K	Sell	1,345 -125	-9%	-$20K	0.13%	134
2023 Q2	$229K	Sell	1,470 -125	-8%	-$20K	0.14%	126
2023 Q1	$259K	Sell	1,595 -385	-19%	-$62.3K	0.17%	108
2022 Q4	$316K	Sell	1,980 -60	-3%	-$9.5K	0.21%	102
2022 Q3	$287K	Sell	2,040 -810	-28%	-$122K	0.2%	97
2022 Q2	$416K	Sell	2,850 -1,880	-40%	-$280K	0.28%	80
2022 Q1	$767K	Sell	4,730 -2,526	-35%	-$409K	0.43%	53
2021 Q4	$1.17M	Sell	7,256 -1,240	-15%	-$239K	0.61%	45
2021 Q3	$1.72M	Buy	8,496 +545	+7%	+$114K	0.84%	32
2021 Q2	$1.58M	Buy	7,951 +905	+13%	+$168K	0.84%	35
2021 Q1	$1.24M	Buy	7,046 +250	+4%	+$45.2K	0.72%	40
2020 Q4	$1.15M	Buy	6,796 +311	+5%	+$51.2K	0.73%	39
2020 Q3	$1.06M	Buy	+6,485	New	+$1.05M	0.76%	38

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIG

Consolidated Investment Group Englewood, Colorado $1.15B AUM 55.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Stonebridge Financial Planning Group's BBH Position: Q4 2023 in Review

Stonebridge Financial Planning Group sold out of VanEck Biotech ETF (BBH) in Q4 2023, closing a stake of 1,345 shares — an estimated $209K sold.

Stonebridge Financial Planning Group first reported a position in BBH in Q3 2020 and held it in 13 quarters. The position peaked at $1.72M in Q3 2021. 116 funds tracked by Wall St. Rank hold BBH as of Q4 2023.

Stonebridge Financial Planning Group reported no remaining VanEck Biotech ETF position as of Q4 2023 after selling out during the quarter.
Stonebridge Financial Planning Group sold 1,345 VanEck Biotech ETF shares in Q4 2023, an estimated $209K.
Stonebridge Financial Planning Group first reported a position in VanEck Biotech ETF in Q3 2020 and held it in 13 quarters.
Stonebridge Financial Planning Group's VanEck Biotech ETF position peaked at $1.72M in Q3 2021.
116 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2023.

Based on Stonebridge Financial Planning Group's 13F filing for Q4 2023, filed 5 Feb 2024.